|
1
|
Rahib L, Smith BD, Aizenberg R, Rosenzweig
AB, Fleshman JM and Matrisian LM: Projecting cancer incidence and
deaths to 2030: The unexpected burden of thyroid, liver and
pancreas cancers in the United States. Cancer Res. 74:2913–2921.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Arciello M and Balsano C: Pathogenesis of
hepatocellular carcinoma: New ideas for a targeted therapy. Hot Top
Viral Hepatitis. 9:272013.
|
|
3
|
Shin JW and Chung YH: Molecular targeted
therapy for hepatocellular carcinoma: Current and future. World J
Gastroenterol. 19:6144–6155. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Page AJ, Weiss MJ and Pawlik TM: Surgical
management of noncolorectal cancer liver metastases. Cancer.
120:3111–3121. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Tomimaru Y, Sasaki Y, Yamada T, Gotoh K,
Noura S, Eguchi H, Miyashiro I, Ohue M, Ohigashi H, Yano M, et al:
Liver metastasis originating from colorectal cancer with
macroscopic portal vein tumor thrombosis: A case report and review
of the literature. J Med Case Rep. 4:3822010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wu DD, Xiao YF, Geng Y and Hou J:
Antitumor effect and mechanisms of arsenic trioxide on
subcutaneously implanted human gastric cancer in nude mice. Cancer
Genet Cytogenet. 198:90–96. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kumar S, Yedjou CG and Tchounwou PB:
Arsenic trioxide induces oxidative stress, DNA damage and
mitochondrial pathway of apoptosis in human leukemia (HL-60) cells.
J Exp Clin Cancer Res. 33:422014. View Article : Google Scholar
|
|
8
|
Fu HY, Shen JZ, Wu Y, Shen SF, Zhou HR and
Fan LP: Arsenic trioxide inhibits DNA methyltransferase and
restores expression of methylation-silenced CDKN2B/CDKN2A genes in
human hematologic malignant cells. Oncol Rep. 24:335–343.
2010.PubMed/NCBI
|
|
9
|
Kim EY, Lee SS, Shin JH, Kim SH, Shin DH
and Baek SY: Anticancer effect of arsenic trioxide on
cholangiocarcinoma: In vitro experiments and in vivo xenograft
mouse model. Clin Exp Med. 14:215–224. 2014. View Article : Google Scholar
|
|
10
|
Liu P, Xu S, Zhang M, Wang WW, Zhang YF,
Rehman K, Naranmandura H and Chen Z: Anticancer activity in human
multiple myeloma U266 cells: Synergy between cryptotanshinone and
arsenic trioxide. Metallomics. 5:871–878. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Liu W, Shibata K, Koya Y, Kajiyama H,
Senga T, Yamashita M and Kikkawa F: B7-H4 overexpression correlates
with a poor prognosis for cervical cancer patients. Mol Clin Oncol.
2:219–225. 2014.PubMed/NCBI
|
|
12
|
Chen L, Lu Y, Wang F, Zhou M, Chu Y, Ding
W, Liu C, Xie J, Wu C and Jiang J: Expression of co-stimulatory
molecule B7-H4 in patients suffering from rheumatoid arthritis.
Immuno Lett. 154:25–30. 2013. View Article : Google Scholar
|
|
13
|
Dangaj D and Scholler N: Blocking the
B7-H4 pathway with novel recombinant antibodies enhances T
cell-mediated antitumor responses. Oncoimmunology. 2:e259132013.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kristensen NN, Schmidt EG, Rasmussen S,
Balk-Møller E and Claesson MH: B7-H4-Ig treatment of normal mice
changes lymphocyte homeostasis and increases the potential of
regulatory T cells. Immunopharmacol Immunotoxicol. 35:505–513.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Cheng L, Jiang J, Gao R, Wei S, Nan F, Li
S and Kong B: B7-H4 expression promotes tumorigenesis in ovarian
cancer. Int J Gynecol Cancer. 19:1481–1486. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Sun Y, Wang Y, Zhao J, Gu M, Giscombe R,
Lefvert AK and Wang X: B7-H3 and B7-H4 expression in non-small-cell
lung cancer. Lung Cancer. 53:143–151. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Darmochwal-Kolarz D, Kludka-Sternik M,
Kolarz B, Chmielewski T, Tabarkiewicz J, Rolinski J,
Leszczynska-Gorzelak B and Oleszczuk J: The expression of B7-H1 and
B7-H4 co-stimulatory molecules on myeloid and plasmacytoid
dendritic cells in pre-eclampsia and normal pregnancy. J Reprod
Immunol. 99:33–38. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
19
|
Abubaker K, Luwor RB, Escalona R, McNally
O, Quinn MA, Thompson EW, Findlay JK and Ahmed N: Targeted
disruption of the JAK2/STAT3 pathway in combination with systemic
administration of paclitaxel inhibits the priming of ovarian cancer
stem cells leading to a reduced tumor burden. Fron Oncol.
4:752014.
|
|
20
|
Li S, Shen X, Yang Z, Wu A, Tang Z, Li M
and Ling Y: Clinical significance of MMP2 overexpression in
endometrial adenocarcinoma. J South Med U. 34:423–425. 2014.In
Chinese.
|
|
21
|
Yilmaz N, Ozaksit G, Terzi YK, Yılmaz S,
Budak B, Aksakal O and Sahin Fİ: HOXA11 and MMP2 gene expression in
uterosacral ligaments of women with pelvic organ prolapse. J Turk
Ger Gynecol Assoc. 15:104–108. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Min BS, Kim NK, Jeong HC and Chung HC:
High levels of serum VEGF and TIMP-1 are correlated with colon
cancer liver metastasis and intrahepatic recurrence after liver
resection. Oncol Lett. 4:123–130. 2012.PubMed/NCBI
|
|
23
|
Huang H, Li Y, Li C, Wang Y, Sun Y and
Wang J: A novel anti-VEGF targeting and MRI-visible smart drug
delivery system for specific diagnosis and therapy of liver cancer.
Macromol Biosci. 13:1358–1368. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Podojil JR, Liu LN, Marshall SA, Chiang
MY, Goings GE, Chen L, Langermann S and Miller SD: B7-H4Ig inhibits
mouse and human T-cell function and treats EAE via
IL-10/Treg-dependent mechanisms. J Autoimmun. 44:71–81. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Krambeck AE, Thompson RH, Dong H, Lohse
CM, Park ES, Kuntz SM, Leibovich BC, Blute ML, Cheville JC and Kwon
ED: B7-H4 expression in renal cell carcinoma and tumor vasculature:
Associations with cancer progression and survival. Proc Natl Acad
Sci USA. 103:10391–10396. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Cheng L, Jiang J, Gao R, Wei S, Nan F, Li
S and Kong B: B7-H4 expression promotes tumorigenesis in ovarian
cancer. Int J Gynecol Cancer. 19:1481–1486. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Qian Y, Hong B, Shen L, Wu Z, Yao H and
Zhang L: B7-H4 enhances oncogenicity and inhibits apoptosis in
pancreatic cancer cells. Cell Tissue Res. 353:139–151. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Sun SQ, Jiang CG, Lin Y, Jin YL and Huang
PL: Enhanced T cell immunity by B7-H4 downregulation in
nonsmall-cell lung cancer cell lines. J Int Med Res. 40:497–506.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Sarkar S, Mukherjee S, Chattopadhyay A and
Bhattacharya S: Low dose of arsenic trioxide triggers oxidative
stress in zebrafish brain: Expression of antioxidant genes.
Ecotoxicol Environ Saf. 107:1–8. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Radenkovic S, Konjevic G, Jurisic V,
Karadzic K, Nikitovic M and Gopcevic K: Values of MMP-2 and MMP-9
in tumor tissue of basal-like breast cancer patients. Cell Biochem
Biophys. 68:143–152. 2014. View Article : Google Scholar
|
|
31
|
Wang J, Shi Q, Yuan TX, Song QL, Zhang Y,
Wei Q, Zhou L, Luo J, Zuo G, Tang M, et al: Matrix
metalloproteinase 9 (MMP-9) in osteosarcoma: Review and
meta-analysis. Clin Chimica Acta. 433:225–231. 2014. View Article : Google Scholar
|
